StockNow
Calendar
Log in
Global Markets

GSK's (GSK LN) Jermperli approved by FDA in MSI-H/dMMR rectal cancer

StockNow breaking-news AI analysis

The breaking-news headline reports FDA approval of GSK’s Jermperli in MSI-H/dMMR rectal cancer; the record provides no further details.

1 stocks
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)$49.62Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Politics

Iranian Navy says that the US military attacked the Konarak naval base with “two light projectiles” early this morning, reports Al Jazeera

Geopolitics

Houthis claim six attacks on Saudi Arabia in 48 hours; strikes include Yanbu Aramco facility, Shaybah oilfield, Riyadh and Abha airports

Geopolitics

IRGC spokesman says does not have the capacity to create a new conflict, Tasnim reports